Nova Eye Medical Limited (EYE.AX)

0,2600 +0,0150 (+6,12%) Börsenschluss: 04:10PM AEST

Nova Eye Medical Limited

107 Rundle Street
Kent Town, SA 5067
Australia
61 8 8362 0193
https://www.nova-eye.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Victor Previn B.E., B.Eng	Founder & Executive Chairman	236,84k	N/A	1958
Mr. Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D.	MD & Executive Director	252,55k	N/A	1962
Liam Cook	Chief Financial Officer	N/A	N/A	N/A
Mr. Keith Byrne	Vice President of Global Operations	N/A	N/A	N/A
Mark Flynn	Investor Relations	N/A	N/A	N/A
Ms. Kate Hunt	Head of Marketing	N/A	N/A	N/A
Dr. David Lubeck M.D.	Chief Medical Officer	N/A	N/A	N/A
Mr. Joaquin V. Wolff	President of Ellex iTrack	N/A	N/A	1958
Ms. Kimberley Menzies	Group Financial Controller & Global Finance Manager	N/A	N/A	N/A
Mr. Simon Jeremy Newton Gray BEc, C.A., CA	Company Secretary	N/A	N/A	1959

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Corporate Governance

Nova Eye Medical Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.